- Award ID
- W81XWH21F0124
- Contractor
- LAULIMA GOVERNMENT SOLUTIONS, LLC
- Sub-agency / office
- Defense Health Agency
- Award amount
- $8,944,153
- Period of performance
- Mar 22, 2021 – Sep 30, 2026
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- PSC AN11
- Place of performance
- SILVER SPRING, MD, 209101022, USA
- Competition
- FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
- Pricing
- COST PLUS FIXED FEE
- Financial breakdown
- Current value $8,944,153 · Obligated $7,995,722 · Potential value $8,944,153 · Latest action obligation $0 · Outlays $510,882
- Parent award
- W81XWH19D0011
Most recent · Modification P00030 · Jun 26, 2026 · $0 action obligation · TWO RESEARCH CLINICAL TRIALS AT THE WALTER REED ARMY INSTITUTE OF RESEARCH · W81XWH21F0124
Modification P00029 · Mar 20, 2026 · $0 action obligation · TWO RESEARCH CLINICAL TRIALS AT THE WALTER REED ARMY INSTITUTE OF RESEARCH · W81XWH21F0124
Modification P00028 · Feb 12, 2026 · $0 action obligation · TWO RESEARCH CLINICAL TRIALS AT THE WALTER REED ARMY INSTITUTE OF RESEARCH · W81XWH21F0124
Modification P00027 · Sep 25, 2025 · $534,964 action obligation · NON PERSONNEL SERVICES FOR TWO RESEARCH CLINICAL TRIALS · W81XWH21F0124
Modification P00026 · Mar 28, 2025 · $348,868 action obligation · RESEARCH SERVICES FOR A CLINICAL TRIAL FOR WALTER REED ARMY INSTITUE OF RESEARCH · W81XWH21F0124
Modification P00025 · Feb 28, 2025 · $0 action obligation · NON-PERSONAL SERVICES FOR RESEARCH CLINICAL TRIALS AT THE WALTER REED ARMY INSTITUTE OF RESEARCH. · W81XWH21F0124
Modification P00024 · Jan 30, 2025 · $0 action obligation · NON-PERSONAL SERVICES FOR RESEARCH CLINICAL TRIALS AT THE WALTER REED ARMY INSTITUTE OF RESEARCH. · W81XWH21F0124
Modification P00023 · Oct 30, 2024 · $0 action obligation · RESEARCH IN SUPPORT OF CLINICAL TRIALS · W81XWH21F0124
Modification P00022 · Aug 15, 2024 · $0 action obligation · RESEARCH CLINICAL TRIALS FOR THE WALTER REED ARMY INSTITUTE OF RESEARCH · W81XWH21F0124
Modification P00021 · Apr 26, 2024 · $1,053,292 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00020 · Jan 10, 2024 · $87,060 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00019 · Nov 30, 2023 · $783,803 action obligation · RESEARCH CLINICAL TRIALS IN SUPPORT OF THE WALTER REED ARMY INSTITUTE OF RESEARCH SILVER SPRING MD · W81XWH21F0124
Modification P00018 · Sep 8, 2023 · $40,000 action obligation · WALTER REED ARMY INSTITUTE OF RESEARCH CLINICAL TRIAL RESEARCH · W81XWH21F0124
Modification P00017 · Apr 28, 2023 · $776,000 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00016 · Mar 9, 2023 · $200,000 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00015 · Dec 22, 2022 · $0 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00014 · Nov 7, 2022 · $250,000 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES INCREMENTAL FUNDING MOD AND PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/1/2022. · W81XWH21F0124
Modification P00013 · Sep 26, 2022 · $135,559 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00012 · Sep 23, 2022 · $-135,559 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00011 · Aug 31, 2022 · $447,541 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00010 · Jun 24, 2022 · $958,092 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00009 · May 25, 2022 · $189,152 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00008 · Mar 30, 2022 · $194,000 action obligation · WRAIR CTC CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00007 · Feb 11, 2022 · $99,571 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124
Modification P00006 · Oct 21, 2021 · $310,000 action obligation · WRAIR CLINICAL TRIAL SUPPORT SERVICES · W81XWH21F0124